C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/4709 (2006.01) A61K 31/4745 (2006.01) A61P 31/12 (2006.01) C07D 215/54 (2006.01) C07D 471/14 (2006.01) C07D 491/14 (2006.01)
Patent
CA 2540021
The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.
La présente invention concerne des composés tétrazoloquinoline qui constituent des inhibiteurs du virus de l'hépatite C (VHC). Cette invention concerne également des compositions renfermant ces composés combinés à un excipient pharmaceutiquement acceptable ainsi que des méthodes d'utilisation de ces composés et compositions pour inhiber une infection par le VHC d'une cellule et en particulier des méthodes de traitement d'une infection par le VHC chez un mammifère.
Argade Ankush
Huang Peiyong
Lu Henry H.
Singh Rajinder
Thota Sambaiah
Mbm Intellectual Property Law Llp
Rigel Pharmaceuticals Inc.
LandOfFree
Hcv inhibitors and methods of using them does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hcv inhibitors and methods of using them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv inhibitors and methods of using them will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1804158